Two stem cell companies derived from UW-Madison research are coming out of the woodwork.
JangoBio says it is developing ways to reverse hormone imbalances tied to aging without the use of traditional hormone replacement therapy.
Using stem cell technology, JangoBio hopes to restore an individual’s regular hormone levels and, in doing so, delay the onset of diseases associated with aging, such as heart disease and dementia.